Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — July 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

BridgeBio Pharma, Inc. (BBIO)

Apuli Maricel — Chief Accounting Officer
Jul 30, 2026
Sale
Shares
2,000
Price
$80.06
Total Value
$160.12K
Shares Held After
127,401
% of Holdings
1.5%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
1,001
Price
$120.67
Total Value
$120.80K
Shares Held After
16,130
% of Holdings
5.8%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
8,103
Price
$119.95
Total Value
$971.94K
Shares Held After
17,131
% of Holdings
32.1%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
4,783
Price
$118.73
Total Value
$567.91K
Shares Held After
25,234
% of Holdings
15.9%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
8,267
Price
$117.93
Total Value
$974.95K
Shares Held After
30,017
% of Holdings
21.6%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
7,089
Price
$116.96
Total Value
$829.10K
Shares Held After
38,284
% of Holdings
15.6%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
14,222
Price
$115.87
Total Value
$1.65M
Shares Held After
45,373
% of Holdings
23.9%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
15,477
Price
$114.96
Total Value
$1.78M
Shares Held After
59,595
% of Holdings
20.6%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
4,700
Price
$113.18
Total Value
$531.94K
Shares Held After
75,072
% of Holdings
5.9%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
600
Price
$110.95
Total Value
$66.57K
Shares Held After
79,772
% of Holdings
0.7%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
2,202
Price
$110.03
Total Value
$242.28K
Shares Held After
80,372
% of Holdings
2.7%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
400
Price
$108.46
Total Value
$43.38K
Shares Held After
82,574
% of Holdings
0.5%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
8,956
Price
$106.96
Total Value
$957.89K
Shares Held After
82,974
% of Holdings
9.7%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jul 30, 2026
Sale
Shares
4,200
Price
$105.54
Total Value
$443.25K
Shares Held After
91,930
% of Holdings
4.4%
Jul 30, 2026
Purchase
Shares
5,600
Price
$0.41
Total Value
$2.30K
Shares Held After
2,857,373
% of Holdings
0.2%
Jul 30, 2026
Purchase
Shares
10,000
Price
$0.40
Total Value
$4.00K
Shares Held After
2,851,773
% of Holdings
0.4%
Jul 30, 2026
Purchase
Shares
20,000
Price
$0.39
Total Value
$7.80K
Shares Held After
2,841,773
% of Holdings
0.7%

INTUITIVE SURGICAL INC (ISRG)

Brosius Mark — EVP&Chief Mfg and Supply Cha
Jul 30, 2026
Sale
Shares
28
Price
$346.83
Total Value
$9.71K
Shares Held After
1,294
% of Holdings
2.1%

ACADIA PHARMACEUTICALS INC (ACAD)

Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Jul 30, 2026
Sale
Shares
50
Price
$26.17
Total Value
$1.31K
Shares Held After
18,994
% of Holdings
0.3%

ACADIA PHARMACEUTICALS INC (ACAD)

Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Jul 30, 2026
Sale
Shares
16,508
Price
$26.13
Total Value
$431.35K
Shares Held After
19,044
% of Holdings
46.4%
Jul 30, 2026
Purchase
Shares
15,000
Price
$53.38
Total Value
$800.70K
Shares Held After
19,000
% of Holdings
78.9%

ANGIODYNAMICS INC (ANGO)

Nighan Warren JR — SVP Quality and Regulatory
Jul 30, 2026
Sale
Shares
23,370
Price
$14.72
Total Value
$344.01K
Shares Held After
64,745
% of Holdings
26.5%
Jul 30, 2026
Sale
Shares
40
Price
$528.96
Total Value
$21.16K
Shares Held After
324,443
% of Holdings
0.0%
Jul 30, 2026
Sale
Shares
400
Price
$526.92
Total Value
$210.77K
Shares Held After
324,483
% of Holdings
0.1%
Jul 30, 2026
Sale
Shares
2,084
Price
$525.80
Total Value
$1.10M
Shares Held After
324,883
% of Holdings
0.6%
Jul 30, 2026
Sale
Shares
4,846
Price
$524.88
Total Value
$2.54M
Shares Held After
326,967
% of Holdings
1.5%
Jul 30, 2026
Sale
Shares
1,486
Price
$523.87
Total Value
$778.48K
Shares Held After
331,813
% of Holdings
0.4%
Jul 30, 2026
Sale
Shares
644
Price
$523.04
Total Value
$336.84K
Shares Held After
333,299
% of Holdings
0.2%

Vericel Corp (VCEL)

SIEGAL JONATHAN — Principal Accounting Officer
Jul 30, 2026
Sale
Shares
500
Price
$48.90
Total Value
$24.45K
Shares Held After
1,078
% of Holdings
31.7%

Vericel Corp (VCEL)

SIEGAL JONATHAN — Principal Accounting Officer
Jul 30, 2026
Sale
Shares
2,500
Price
$48.90
Total Value
$122.25K
Shares Held After
1,078
% of Holdings
69.9%

Vericel Corp (VCEL)

SIEGAL JONATHAN — Principal Accounting Officer
Jul 30, 2026
Sale
Shares
1,500
Price
$48.90
Total Value
$73.35K
Shares Held After
1,078
% of Holdings
58.2%
Jul 30, 2026
Sale
Shares
558,633
Price
$8.20
Total Value
$4.58M
Shares Held After
6,633,314
% of Holdings
7.8%
Jul 30, 2026
Purchase
Shares
1,000,000
Price
$13.00
Total Value
$13.00M
Shares Held After
20,906,689
% of Holdings
4.8%

Nurix Therapeutics, Inc. (NRIX)

Hansen Gwenn — Chief Scientific Officer
Jul 30, 2026
Sale
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
121,338
% of Holdings
3.1%

Nurix Therapeutics, Inc. (NRIX)

van Houte Hans — Chief Financial Officer
Jul 30, 2026
Sale
Shares
2,845
Price
$23.38
Total Value
$66.52K
Shares Held After
44,927
% of Holdings
6.0%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Jul 30, 2026
Sale
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
19,912
% of Holdings
16.2%
Jul 30, 2026
Sale
Shares
146
Price
$86.03
Total Value
$12.59K
Shares Held After
21,534
% of Holdings
0.7%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Jul 30, 2026
Sale
Shares
14,000
Price
$79.88
Total Value
$1.12M
Shares Held After
58,555
% of Holdings
19.3%

TENET HEALTHCARE CORP (THC)

Foo Lisa Y — EVP, Chief Operating Officer
Jul 29, 2026
Sale
Shares
10,000
Price
$258.03
Total Value
$2.58M
Shares Held After
32,053
% of Holdings
23.8%
Jul 29, 2026
Purchase
Shares
34,722
Price
$5.76
Total Value
$200.00K
Shares Held After
34,822
% of Holdings
99.7%
Jul 29, 2026
Purchase
Shares
20,824
Price
$9.99
Total Value
$208.03K
Shares Held After
17,304,626
% of Holdings
0.1%

IQVIA HOLDINGS INC. (IQV)

Cherofsky Keriann — SVP, Corporate Controller Power of Attorney
Jul 29, 2026
Sale
Shares
558
Price
$245.21
Total Value
$136.83K
Shares Held After
2,989
% of Holdings
15.7%

IQVIA HOLDINGS INC. (IQV)

Sherbet Eric — Executive Vice President, General Counsel Power of Attorney
Jul 29, 2026
Sale
Shares
5,000
Price
$249.16
Total Value
$1.25M
Shares Held After
20,999
% of Holdings
19.2%
Jul 29, 2026
Sale
Shares
53,191
Price
$244.78
Total Value
$13.02M
Shares Held After
885,868
% of Holdings
5.7%
Jul 29, 2026
Sale
Shares
44,039
Price
$246.08
Total Value
$10.84M
Shares Held After
939,059
% of Holdings
4.5%
Jul 29, 2026
Sale
Shares
4,584
Price
$246.85
Total Value
$1.13M
Shares Held After
983,098
% of Holdings
0.5%
Jul 29, 2026
Sale
Shares
4,465
Price
$247.10
Total Value
$1.10M
Shares Held After
987,682
% of Holdings
0.5%
Jul 29, 2026
Purchase
Shares
7,736
Price
$2.58
Total Value
$20.00K
Shares Held After
41,644
% of Holdings
18.6%

DBV Technologies S.A. (DBVT)

Mohideen Pharis — Chief Medical Officer
Jul 29, 2026
Sale
Shares
464
Price
$2.70
Total Value
$1.25K
Shares Held After
144,531
% of Holdings
0.3%

HCW Biologics Inc. (HCWB)

Wong Hing C — Director
Jul 29, 2026
Purchase
Shares
23,210
Price
$2.58
Total Value
$60.00K
Shares Held After
125,845
% of Holdings
18.4%
Version: v26.7.3